LeMaitre Vascular Inc (NASDAQ: LMAT) has reported E.P.S. of $0.50 for its fourth fiscal quarter (ending December 31) versus $0.38 for the same period a year ago — an increase of 32%. For the latest four quarters through December 31, E.P.S. were $1.96 compared to $1.36 a year ago — an increase of 44%.
Recent Price Action
LeMaitre Vascular Inc (NASDAQ: LMAT) stock declined by -3.0% on 2/27/25. The shares closed at $99.91. Moreover, above average trading volume at 120% of normal accompanied the decline. The stock has been strong relative to the market over the last nine months but has declined -3.1% during the last week.
Current PriceTarget Research Rating
LeMaitre Vascular has a current Value Trend Rating of C (Low Neutral). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. LeMaitre Vascular has a poor Appreciation Score of 15 but a good Power Rating of 80, producing the Low Neutral Value Trend Rating.
Rating Review
In light of this new information we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment